Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)

• Company Description    Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California. Number of Employees: 979

• Price / Volume Information    Yesterday's Closing Price: $90.27 Daily Weekly Monthly 20 Day Moving Average: 1,486,997 shares Shares Outstanding: 62.27 (millions) Market Capitalization: $5,621.20 (millions) Beta: 2.11 52 Week High: $105.47 52 Week Low: $23.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.60% -7.29% 12 Week 54.44% 50.21% Year To Date 184.58% 169.29%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 681 GATEWAY BLVD. - SOUTH SAN FRANCISCO,CA 94080 USA ph: 800-719-0671 fax: - abitting@twistbioscience.com http://www.twistbioscience.com

• General Corporate Information    Officers Emily M. Leproust - Chief Executive Officer and Chair of the Board of Adam Laponis - Chief Financial Officer Robert F. Werner - Chief Accounting Officer Nelson C. Chan - Director Robert Chess - Director Peer Information Twist Bioscience Corporation (CORR.) Twist Bioscience Corporation (RSPI) Twist Bioscience Corporation (CGXP) Twist Bioscience Corporation (BGEN) Twist Bioscience Corporation (GTBP) Twist Bioscience Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90184D100 SIC: 2836 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/03/26 Share - Related Items Shares Outstanding: 62.27 Most Recent Split Date: (:1) Beta: 2.11 Market Capitalization: $5,621.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.02 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 12.35 Price/Cash Flow: - Price / Sales: 13.73 EPS Growth vs. Year Ago Period: 6.06% vs. Previous Quarter: -24.00% Sales Growth vs. Year Ago Period: 19.31% vs. Previous Quarter: 6.77% ROE 06/30/26 - - 03/31/26 - -26.73 12/31/25 - -27.16 ROA 06/30/26 - - 03/31/26 - -19.15 12/31/25 - -19.92 Current Ratio 06/30/26 - - 03/31/26 - 2.70 12/31/25 - 3.78 Quick Ratio 06/30/26 - - 03/31/26 - 2.42 12/31/25 - 3.37 Operating Margin 06/30/26 - - 03/31/26 - -30.39 12/31/25 - -32.03 Net Margin 06/30/26 - - 03/31/26 - -19.85 12/31/25 - -19.56 Pre-Tax Margin 06/30/26 - - 03/31/26 - -19.67 12/31/25 - -19.33 Book Value 06/30/26 - - 03/31/26 - 7.31 12/31/25 - 7.44 Inventory Turnover 06/30/26 - - 03/31/26 - 6.50 12/31/25 - 7.01 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.03 12/31/25 - 0.03 Debt-to-Capital 06/30/26 - - 03/31/26 - 3.19 12/31/25 - 3.18

Powered by Zacks Investment Research ©